The global Metabolic Disorders Drugs market size was estimated to be US$ 61.5 billion in 2021 and is expected grow at a CAGR of 7.2% between 2023 to 2032.Diseases related to metabolism are caused by improper or dysfunctional natural metabolism. In addition to being brought on by genetic birth abnormalities, disorder.